https://www.statnews.com/2025/07/17/blenrep-advisory-committee-fda-gsk-multiple-myeloma/
0
0
7/17/25 at 5:59pm
Organization
STAT
Author
Andrew Joseph
38 words
0
Comments
FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the selected dose
You are the first to view
Create an account
or login to join the discussion